Literature DB >> 28599149

An optimized lentiviral vector system for conditional RNAi and efficient cloning of microRNA embedded short hairpin RNA libraries.

Felix F Adams1, Dirk Heckl2, Thomas Hoffmann3, Steven R Talbot4, Arnold Kloos5, Felicitas Thol5, Michael Heuser5, Johannes Zuber3, Axel Schambach6, Adrian Schwarzer7.   

Abstract

RNA interference (RNAi) and CRISPR-Cas9-based screening systems have emerged as powerful and complementary tools to unravel genetic dependencies through systematic gain- and loss-of-function studies. In recent years, a series of technical advances helped to enhance the performance of virally delivered RNAi. For instance, the incorporation of short hairpin RNAs (shRNAs) into endogenous microRNA contexts (shRNAmiRs) allows the use of Tet-regulated promoters for synchronous onset of gene knockdown and precise interrogation of gene dosage effects. However, remaining challenges include lack of efficient cloning strategies, inconsistent knockdown potencies and leaky expression. Here, we present a simple, one-step cloning approach for rapid and efficient cloning of miR-30 shRNAmiR libraries. We combined a human miR-30 backbone retaining native flanking sequences with an optimized all-in-one lentiviral vector system for conditional RNAi to generate a versatile toolbox characterized by higher doxycycline sensitivity, reduced leakiness and enhanced titer. Furthermore, refinement of existing shRNA design rules resulted in substantially improved prediction of powerful shRNAs. Our approach was validated by accurate quantification of the knockdown potency of over 250 single shRNAmiRs. To facilitate access and use by the scientific community, an online tool was developed for the automated design of refined shRNA-coding oligonucleotides ready for cloning into our system.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Knockdown; Lentiviral vector; RNAi; Tet-regulation; miR-30; shRNA

Mesh:

Substances:

Year:  2017        PMID: 28599149     DOI: 10.1016/j.biomaterials.2017.05.032

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  9 in total

1.  The plasma membrane H+-ATPase is critical for cell growth and pathogenicity in Penicillium digitatum.

Authors:  Jie Li; Shuzhen Yang; Dongmei Li; Litao Peng; Gang Fan; Siyi Pan
Journal:  Appl Microbiol Biotechnol       Date:  2022-06-30       Impact factor: 5.560

2.  Reprogramming enriches for somatic cell clones with small-scale mutations in cancer-associated genes.

Authors:  Maike Kosanke; Katarzyna Osetek; Alexandra Haase; Lutz Wiehlmann; Colin Davenport; Adrian Schwarzer; Felix Adams; Marc-Jens Kleppa; Axel Schambach; Sylvia Merkert; Stephanie Wunderlich; Sandra Menke; Marie Dorda; Ulrich Martin
Journal:  Mol Ther       Date:  2021-04-06       Impact factor: 12.910

3.  Design and implementation of a synthetic pre-miR switch for controlling miRNA biogenesis in mammals.

Authors:  Janina Atanasov; Florian Groher; Julia E Weigand; Beatrix Suess
Journal:  Nucleic Acids Res       Date:  2017-12-15       Impact factor: 16.971

4.  Refined sgRNA efficacy prediction improves large- and small-scale CRISPR-Cas9 applications.

Authors:  Maurice Labuhn; Felix F Adams; Michelle Ng; Sabine Knoess; Axel Schambach; Emmanuelle M Charpentier; Adrian Schwarzer; Juan L Mateo; Jan-Henning Klusmann; Dirk Heckl
Journal:  Nucleic Acids Res       Date:  2018-02-16       Impact factor: 16.971

5.  Distinct genetic pathways define pre-malignant versus compensatory clonal hematopoiesis in Shwachman-Diamond syndrome.

Authors:  Akiko Shimamura; R Coleman Lindsley; Alyssa L Kennedy; Kasiani C Myers; James Bowman; Christopher J Gibson; Nicholas D Camarda; Elissa Furutani; Gwen M Muscato; Robert H Klein; Kaitlyn Ballotti; Shanshan Liu; Chad E Harris; Ashley Galvin; Maggie Malsch; David Dale; John M Gansner; Taizo A Nakano; Alison Bertuch; Adrianna Vlachos; Jeffrey M Lipton; Paul Castillo; James Connelly; Jane Churpek; John R Edwards; Nobuko Hijiya; Richard H Ho; Inga Hofmann; James N Huang; Siobán Keel; Adam Lamble; Bonnie W Lau; Maxim Norkin; Elliot Stieglitz; Wendy Stock; Kelly Walkovich; Steffen Boettcher; Christian Brendel; Mark D Fleming; Stella M Davies; Edie A Weller; Christopher Bahl; Scott L Carter
Journal:  Nat Commun       Date:  2021-02-26       Impact factor: 14.919

6.  miR-AB, a miRNA-based shRNA viral toolkit for multicolor-barcoded multiplex RNAi at a single-cell level.

Authors:  Dapeng Wang; Jianbo Xiu; Jiangyue Zhao; Junli Luo
Journal:  EMBO Rep       Date:  2022-02-24       Impact factor: 8.807

7.  hiPSC-derived bone marrow milieu identifies a clinically actionable driver of niche-mediated treatment resistance in leukemia.

Authors:  Deepali Pal; Helen Blair; Jessica Parker; Sean Hockney; Melanie Beckett; Mankaran Singh; Ricky Tirtakusuma; Ryan Nelson; Hesta McNeill; Sharon H Angel; Aaron Wilson; Salem Nizami; Sirintra Nakjang; Peixun Zhou; Claire Schwab; Paul Sinclair; Lisa J Russell; Jonathan Coxhead; Christina Halsey; James M Allan; Christine J Harrison; Anthony V Moorman; Olaf Heidenreich; Josef Vormoor
Journal:  Cell Rep Med       Date:  2022-08-16

8.  Development of a novel method for rapid cloning of shRNA vectors, which successfully knocked down CD44 in mesenchymal triple-negative breast cancer cells.

Authors:  Lei Zhou; Dandan Sheng; Qiaodan Deng; Dong Wang; Suling Liu
Journal:  Cancer Commun (Lond)       Date:  2018-09-24

9.  MiR-30b-5p regulates the lipid metabolism by targeting PPARGC1A in Huh-7 cell line.

Authors:  Qing Zhang; Xue-Feng Ma; Meng-Zhen Dong; Jie Tan; Jie Zhang; Li-Kun Zhuang; Shou-Sheng Liu; Yong-Ning Xin
Journal:  Lipids Health Dis       Date:  2020-04-16       Impact factor: 3.876

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.